LYEL
Lyell Immunopharma (LYEL)
$48
About Lyell Immunopharma (LYEL)
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.
Details
Daily high
$0.49
Daily low
$0.46
Price at open
$0.49
52 Week High
$2.88
52 Week Low
$0.39
Market cap
135.8M
Dividend yield
0.00%
Volume
657,300
Avg. volume
731,175
P/E ratio
-.35
Lyell Immunopharma News
Details
Daily high
$0.49
Daily low
$0.46
Price at open
$0.49
52 Week High
$2.88
52 Week Low
$0.39
Market cap
135.8M
Dividend yield
0.00%
Volume
657,300
Avg. volume
731,175
P/E ratio
-.35